Man Group’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.29M Buy
256,918
+164,727
+179% +$830K ﹤0.01% 1349
2025
Q1
$597K Buy
+92,191
New +$597K ﹤0.01% 1523
2023
Q4
Hold
0
-$127K 2141
2023
Q3
Sell
-297,527
Closed -$7.3M 1791
2023
Q2
$7.3M Buy
+297,527
New +$7.3M 0.02% 734
2023
Q1
Sell
-67,344
Closed -$1.7M 642
2022
Q4
$1.7M Sell
67,344
-93,895
-58% -$2.38M 0.01% 1157
2022
Q3
$3.11M Buy
+161,239
New +$3.11M 0.01% 913
2022
Q2
Sell
-166,391
Closed -$4.28M 566
2022
Q1
$4.28M Buy
166,391
+109,637
+193% +$2.82M 0.01% 942
2021
Q4
$2.38M Buy
56,754
+43,522
+329% +$1.82M 0.01% 1128
2021
Q3
$575K Buy
13,232
+5,224
+65% +$227K ﹤0.01% 1486
2021
Q2
$378K Buy
8,008
+695
+10% +$32.8K ﹤0.01% 1626
2021
Q1
$375K Sell
7,313
-9,818
-57% -$503K ﹤0.01% 1574
2020
Q4
$458K Buy
+17,131
New +$458K ﹤0.01% 1574
2020
Q3
Sell
-39,407
Closed -$1.62M 1876
2020
Q2
$1.62M Buy
+39,407
New +$1.62M 0.01% 1128